113 related articles for article (PubMed ID: 2784234)
21. Ozone effects on alpha-1-proteinase inhibitor in vivo: blood plasma inhibitory activity is unchanged.
Johnson DA; Winters RS; Woolley T; Graham D; Henderson FW
Exp Lung Res; 1986; 11(2):95-103. PubMed ID: 3489611
[TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of granulocytic elastase-alpha 1-proteinase inhibitor complex in patients with severe head injury, multiple trauma or cerebral bleeding.
Harm K; Bartfeld KP; Mathew T
Clin Biochem; 1989 Apr; 22(2):149-53. PubMed ID: 2785881
[TBL] [Abstract][Full Text] [Related]
23. Enzyme-linked immunoassay for human granulocyte elastase in complex with alpha 1-proteinase inhibitor.
Neumann S; Hennrich N; Gunzer G; Lang H
Adv Exp Med Biol; 1984; 167():379-90. PubMed ID: 6608861
[TBL] [Abstract][Full Text] [Related]
24. Elastase-alpha 1-proteinase inhibitor in early diagnosis of neonatal septicemia.
Speer CP; Ninjo A; Gahr M
J Pediatr; 1986 Jun; 108(6):987-90. PubMed ID: 3486969
[No Abstract] [Full Text] [Related]
25. Elevation of plasma truncated elastase alpha 1-proteinase inhibitor complexes in patients with inflammatory lung diseases.
Fujita J; Nakamura H; Yamagishi Y; Yamaji Y; Shiotani T; Irino S
Chest; 1992 Jul; 102(1):129-34. PubMed ID: 1623739
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen split products, antiproteases and granulocytic elastase in patients with lung cancer.
Gropp C; Egbring R; Havemann K
Eur J Cancer (1965); 1980 May; 16(5):679-85. PubMed ID: 6967016
[No Abstract] [Full Text] [Related]
27. Acute promyelocytic leukemia developed in a patient with congenital antithrombin III deficiency.
Moriki T; Murata M; Kizaki M; Kawai Y; Watanabe K; Ikeda Y
Int J Hematol; 1995 Jan; 61(1):39-42. PubMed ID: 7718768
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
29. Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.
Sterrenberg L; Haak HL; Brommer EJ; Nieuwenhuizen W
Haemostasis; 1985; 15(2):126-33. PubMed ID: 3859461
[TBL] [Abstract][Full Text] [Related]
30. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
31. Elastase activity in leukaemic cells and plasma in patients with acute leukaemia.
Törnebohm E; Egberg N; Sablica H; Wallin R; Lockner D; Paul C
Eur J Haematol; 1992 Aug; 49(2):98-104. PubMed ID: 1397247
[TBL] [Abstract][Full Text] [Related]
32. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
[TBL] [Abstract][Full Text] [Related]
33. Studies on the interactions of human pancreatic elastase 2 with human alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
Davril M; Laine A; Hayem A
Biochem J; 1987 Aug; 245(3):699-704. PubMed ID: 3499146
[TBL] [Abstract][Full Text] [Related]
34. Serum antiproteases in smokers and nonsmokers. Relationships to smoking status and pulmonary function.
Bridges RB; Kimmel DA; Wyatt RJ; Rehm SR
Am Rev Respir Dis; 1985 Dec; 132(6):1162-9. PubMed ID: 3878111
[TBL] [Abstract][Full Text] [Related]
35. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
[TBL] [Abstract][Full Text] [Related]
36. Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.
Perlmutter DH; Travis J; Punsal PI
J Clin Invest; 1988 Jun; 81(6):1774-80. PubMed ID: 3260245
[TBL] [Abstract][Full Text] [Related]
37. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
38. The role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia.
Federici AB; D'Amico EA
Leuk Lymphoma; 1998 Nov; 31(5-6):491-9. PubMed ID: 9922039
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte lysosomal factors and plasma elastase in uremia: a potential factor of catabolism.
Heidland A; Hörl WH; Heller N; Heine H; Neumann S; Schaefer RM; Heidbreder E
Klin Wochenschr; 1984 Mar; 62(5):218-24. PubMed ID: 6201647
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
